509
Participants
Start Date
September 14, 2015
Primary Completion Date
December 5, 2018
Study Completion Date
June 27, 2024
Olaratumab
Administered IV
Doxorubicin
Administered IV
Placebo
Administered IV
Chang Gung Memorial Hospital - Linkou, Taoyuan Hsien
Magyar Honvedseg Egeszsegugyi Kozpont, Budapest
AKH, Vienna
Cliniques universitaires Saint-Luc, Brussels
Alexander Fleming, CABA
Chris O'Brien Lifehouse, Camperdown
Herlev and Gentofte Hospital, Herlev
Universitaire Ziekenhuizen Leuven - Campus Gasthuisberg, Leuven
Inselspital Bern, Bern
Universitair Ziekenhuis Gent, Ghent
Cantonal Hospital St.Gallen, Sankt Gallen
National Taiwan University Hospital, Taipei
Columbia University Medical Center, New York
Istituto di Candiolo IRCCS - Fondazione del Piemonte per l'Oncologia, Candiolo
Memorial Sloan Kettering Cancer Center, New York
National Cancer Center, Goyang-si
Taipei Veterans General Hospital, Taipei
HELIOS Klinikum Berlin-Buch, Berlin
CHU Hopital d'enfants de la Timone, Marseille
University of Pittsburgh Medical Center, Pittsburgh
Pennsylvania Oncology Hematology Associates, Philadelphia
Istituto Clinico Humanitas, Rozzano
Istituto Nazionale dei Tumori, Milan
Centre Georges François Leclerc, Dijon
Hospital Angeles, Tijuana
Fairfax Northern Virginia Hematology Oncology, PC, Fairfax
Skånes universitetssjukhus Lund, Lund
Duke Cancer Institute, Durham
Hospital Clinico San Carlos, Madrid
Hospital Universitario 12 de Octubre, Madrid
Georgia Cancer Specialists PC, Atlanta
Institut Claudius Regaud, Toulouse
Mayo Clinic in Florida, Jacksonville
Institut Bergonié - Centre Régional de Lutte Contre Le Cancer de Bordeaux et Sud Ouest, Bordeaux
Tampereen yliopistollinen sairaala, Tampere
Moffitt Cancer Center & Research Institute, Tampa
Oncology Hematology Care Inc, Nashville
Tennessee Oncology PLLC, Nashville
The West Clinic, Germantown
Hospital Universitario Virgen Del Rocio, Seville
Hospital Civil Fray Antonio Alcalde, Guadalajara
Oncology Hematology Care Inc, Fairfield
Universitaetsklinikum Essen, Essen
Oncology Hematology Care Inc, Cincinnati
Oncology Hematology Care Inc, Cincinnati
Oncology Hematology Care Inc, Cincinnati
Oncology Hematology Care Inc, Cincinnati
Hospital Universitario La Fe de Valencia, Valencia
University of Michigan, Ann Arbor
Washington University Medical School, St Louis
Consultorio Dr. Reinoso, Monterrey
Nebraska Methodist Cancer Center, Omaha
Klinikum Mannheim gGmbH Universitätsmedizin, Mannheim
Centre Leon Berard, Lyon
Universitätsklinikum Tübingen, Tübingen
Institut Curie, Paris
Centro de Alta Especialidad Reumatologia Inv del Potosi SC, San Luis Potosí City
University of Colorado Cancer Center, Aurora
Klinikum der Universität München Großhadern, München
Utah Cancer Specialists, Salt Lake City
University of Utah School of Medicine, Salt Lake City
University of New Mexico Cancer Center, Albuquerque
UCLA Medical Center, Los Angeles
Stanford University, Stanford
Gustave Roussy, Villejuif
Università degli Studi di Catania - Azienda Policlinico, Catania
Centro de Atención E Investigación Clínica En Oncología, Mérida
Oregon Health and Science University, Portland
Blokhin Cancer Research Center, Moscow
St-Petersburg scientifical practical cente spec medical care, Saint Petersburg
Kazan Oncology Dispensary, Kazan'
Sheba Medical Center, Tel Litwinsky
Tel Aviv Sourasky Medical Center, Tel Aviv
Hadassah Medical Center, Jerusalem
City of Hope National Medical Center, Duarte
Dana Farber Cancer Institute, Boston
Vanderbilt University Medical Center, Nashville
CENIT Centro de Neurociencias, Investigación y Tratamiento, Caba
Hospital Provincial del Centenario, Rosario
INCA Hospital do Câncer III, Rio de Janeiro
Icesp - Instituto Do Câncer Do Estado de São Paulo, São Paulo
Tom Baker Cancer Center, Calgary
BC Cancer Vancouver, Vancouver
Princess Margaret Hospital (Ontario), Lai Chi Kok
Royal Victoria Hospital-Montreal, Montreal
Turku University Central Hospital, Turku
Nagoya University Hospital, Nagoya
National Cancer Center Hospital East, Kashiwa
National Hospital Organization Hokkaido Cancer Center, Sapporo
Osaka University Hospital, Suita
Saitama Medical University International Medical Center, Hidaka
National Cancer Center Hospital, Chuo-Ku
Japanese Foundation for Cancer Research, Koto-ku
National Hospital Organization Kyushu Cancer Center, Fukuoka
Okayama University Hospital, Okayama
National Hospital Organization Osaka National Hospital, Osaka
Osaka International Cancer Institute, Osaka
Maastricht UMC+, Maastricht
University Medical Center Groningen, Groningen
Leids Universitair Medisch Centrum, Leiden
Universitair Medisch Centrum St Radboud Nijmegen, Nijmegen
Erasmus Medisch Centrum, Rotterdam
Narodowy Instytut Onkologii im. Marii Sklodowskiej-Curie Panstwowy Instytut Badawczy, Warsaw
Asan Medical Center, Seoul
Seoul St. Mary's Hospital, Seoul
Severance Hospital, Yonsei University Health System, Seoul
Samsung Medical Center, Seoul
Hospital Universitari Vall d'Hebron, Barcelona
Hospital Duran I Reynals, Barcelona
University College Hospital - London, London
Royal Marsden NHS Trust, London
The Christie NHS Foundation Trust, Manchester
The Clatterbridge Cancer Centre, Bebbington
Weston Park Hospital, Sheffield
Eli Lilly and Company
INDUSTRY